Companies / Rapport Therapeutics, Inc. / Activity
Activity — Rapport Therapeutics, Inc.
7 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jan 20, 2026 | Ceesay Abraham CEO | Sell | Common Stock | $152.3K | -6K -1.03% | 562,080 1.17% of shares | medium |
| Jan 20, 2026 | Ceesay Abraham CEO | Sell | Common Stock | $132.7K | -5K -16.45% | 25,812 0.05% of shares | medium |
| Feb 18, 2026 | Ceesay Abraham CEO | Sell | Common Stock | $103.2K | -4K -0.63% | 558,528 1.16% of shares | medium |
| Feb 18, 2026 | Ceesay Abraham CEO | Sell | Common Stock | $86.6K | -3K -11.56% | 22,829 0.05% of shares | low |
| Feb 18, 2026 | Ceesay Abraham CEO | Sell | Common Stock | $68.0K | -2K -0.41% | 556,247 1.16% of shares | low |
| Feb 18, 2026 | Ceesay Abraham CEO | Sell | Common Stock | $62.6K | -2K -9.20% | 20,729 0.04% of shares | low |
| Feb 2, 2026 | Ceesay Abraham CEO | Grant | Stock Option (Right to Buy) | — | +428K | 428,000 0.89% of shares | low |